Burgueño-García Iván, López-Martínez María José, Uceda-Heras Alicia, García-Carracedo Lucía, Zea-Sevilla María Ascensión, Rodrigo-Lara Héctor, Rego-García Iago, Saiz-Aúz Laura, Ruiz-Valderrey Paloma, López-González Francisco J, Guerra-Martín Virginia, Rábano Alberto
Reina Sofía Alzheimer Center, CIEN Foundation, ISCIII, 28031 Madrid, Spain.
Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.
J Clin Med. 2024 Nov 10;13(22):6755. doi: 10.3390/jcm13226755.
: Clinicopathological research in late-life dementia has focused recently on combined neurodegenerative and vascular conditions underlying the high phenotypic heterogeneity of patients. The Vallecas Alzheimer's Reina Sofía (VARS) cohort (n > 550), and particularly the series of associated brain donations (VARSpath cohort) are presented here. The aim of this study is to contribute to research in dementia with a well-characterized cohort from a single center. : A total of 167 patients with complete neuropathological work-ups were analyzed here. The cohort is characterized by a high female predominance (79%), advanced age at death (88 yrs.), and a high frequency of ApoE-e4 haplotype (43%). : The main neuropathological diagnosis was Alzheimer's disease (79.6%), followed by vascular dementia (10.2%) and Lewy body dementia (6%). Overall, intermediate-to-high cerebrovascular disease was observed in 38.9%, Lewy body pathology in 57.5%, LATE (TDP-43 pathology) in 70.7%, ARTAG in 53%, and argyrophilic grain disease in 12% of the patients. More than one pathology with a clinically relevant burden of disease was present in 71.1% of the brains, and a selection of premortem neuropsychological and functional scores showed significant correlation with the number of co-pathologies identified in postmortem brains. : The VARS cohort, with thorough clinical follow-up, regular blood sampling, 3-Tesla MR, and a high rate of postmortem brain donation, can provide essential multidisciplinary data in the rising age of modifying therapies and biomarkers for Alzheimer's disease and related dementias.
晚年痴呆的临床病理研究最近聚焦于患者高度表型异质性背后的神经退行性和血管性合并病症。本文介绍了巴列卡斯阿尔茨海默病雷纳·索菲亚(VARS)队列(n>550),特别是相关脑捐赠系列(VARSpath队列)。本研究的目的是通过来自单一中心的特征明确的队列,为痴呆研究做出贡献。:本文分析了167例接受完整神经病理学检查的患者。该队列的特点是女性占主导(79%)、死亡时年龄较大(88岁)以及ApoE-e4单倍型频率较高(43%)。:主要神经病理学诊断为阿尔茨海默病(79.6%),其次是血管性痴呆(10.2%)和路易体痴呆(6%)。总体而言,38.9%的患者观察到中度至高度脑血管疾病,57.5%的患者有路易体病理,70.7%的患者有LATE(TDP-43病理),53%的患者有ARTAG,12%的患者有嗜银颗粒病。71.1%的脑存在一种以上具有临床相关疾病负担的病理,一系列生前神经心理学和功能评分与死后脑中鉴定出的共病数量显著相关。:VARS队列具有全面的临床随访、定期血液采样、3特斯拉磁共振成像以及高比例的死后脑捐赠,在阿尔茨海默病及相关痴呆的治疗和生物标志物不断发展的时代,可以提供重要的多学科数据。